Murchinson Ltd. 13D and 13G filings for Immix Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-03-02 2:57 pm Sale | 2022-02-25 | 13G | Immix Biopharma, Inc. IMMX | Murchinson Ltd. | 0 0.000% | -695,600 (Position Closed) | Filing |
| 2022-02-09 5:12 pm Purchase | 2021-12-31 | 13G | Immix Biopharma, Inc. IMMX | Murchinson Ltd. | 695,600 5.280% | 695,600 (New Position) | Filing |